Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07133464 · ClinicalTrials.gov registry record
CDH1-associated Blepharocheilodontic Syndrome Registry
A clinical trial of Blepharocheilodontic Syndrome, sponsored by Ohio State University.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT07133464: Recruiting study of Blepharocheilodontic Syndrome, sponsored by Ohio State University.
NCT07133464 is a study of Blepharocheilodontic Syndrome that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07133464, a study of Blepharocheilodontic Syndrome, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the CDH1-associated Blepharocheilodontic Syndrome (BCDS) registry is to better characterize the clinical features of this condition and exploring whether CDH1 variants linked to BCDS may also increase cancer risk.
Primary Outcome
Reporting of currently known clinical characteristics of CDH1-associated Blepharocheilodontic Syndrome (BCDS), including but not limited to cleft lip and/or palate, eyelid anomalies, dental abnormalities, webbed toes, and imperforate anus. The study will also document additional clinical features that may not have been previously reported in the literature, with the goal of expanding the phenotypic understanding of this rare condition.
Conditions Studied
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-06-17 |
| Est. Completion | 2040-01 |
What NCT07133464 shows while recruiting
NCT07133464 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Blepharocheilodontic Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT07133464 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07133464 about?
NCT07133464 is a clinical study titled "CDH1-associated Blepharocheilodontic Syndrome Registry". The aim of the CDH1-associated Blepharocheilodontic Syndrome (BCDS) registry is to better characterize the clinical features of this condition and exploring whether CDH1 variants linked to BCDS may also increase cancer risk.
What is the current status of trial NCT07133464?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-06-17. Estimated completion is 2040-01.
What conditions does trial NCT07133464 study?
This clinical trial studies the following conditions: Blepharocheilodontic Syndrome.
Who is sponsoring clinical trial NCT07133464?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07133464 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI